Preview Mode Links will not work in preview mode

Coronavirus (COVID-19) Q&A

Feb 26, 2021

The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.

Related Article(s):

SARS-CoV-2 Vaccines